Abstract
Background
Although intestinal Behçet's disease has been treated anecdotally with various therapeutic modalities, clinical evidence regarding management of intestinal Behçet's disease is lacking. The objective of this study was to develop consensus-based practice guidelines for diagnosis and treatment of intestinal Behçet's disease by using a modified Delphi approach.
Methods
Three groups of Japanese gastroenterology specialists were involved in the study: moderators, an expert panel, and a professional group. Clinical statements for ratings were extracted from relevant literature, a survey of the professional group, and by discussion among the expert panel. The expert panel rated the clinical statements according to a nine point scale. After the first round of ratings, a panelist meeting was held to discuss areas of disagreement and to clarify areas of uncertainty. The list of clinical statements was revised after the panelist meeting, and a second round of rating was conducted.
Results
Thirty-two relevant articles were selected in a literature search, and 35 clinical statements were extracted. An additional 209 clinical statements were developed from the survey and discussion among gastroenterology specialists. In the first and second rounds, 56% and 60% of statements, respectively, received median scores ≥7. The range of scores decreased considerably from the first to the second round.
Conclusions
5-Aminosalycylic acid, corticosteroids, immunosuppressants, enteral nutrition, total parenteral nutrition, and surgical therapy were considered standard therapy for intestinal Behçet's disease. Infliximab, colchicines, thalidomide, other pharmacological therapy, endoscopic therapy, and leukocytapheresis were deemed experimental therapy. Based on a two-round modified Delphi approach, practice guidelines for diagnosis and treatment of intestinal Behçet's disease were developed.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
RA Garton JV Ghate JL Jorizzo (2005) Behçet's disease ED Harris SuffixJr RC Budd MC Genovese GS Firestein JS Sargent CB Sledge (Eds) Textbook of rheumatology EditionNumber7th ed Saunders Philadelphia
N Dilsen (1996) ArticleTitleHistory and development of Behçet's disease Rev Rhum Engl Ed 63 512–9 Occurrence Handle8896069 Occurrence Handle1:STN:280:ByiD2M7jtlU%3D
Smith EL, Schur PH. Treatment of Behçet's disease. In Rose, BD, editor. UpToDate, Waltham, MA; 2004
T Sakane M Takeno N Suzuki G Inaba (1999) ArticleTitleCurrent concepts: Behçet disease New Eng J Med 341 1284–91 Occurrence Handle10528040 Occurrence Handle10.1056/NEJM199910213411707 Occurrence Handle1:STN:280:DyaK1Mvkt1aktg%3D%3D
LJ Brandt SJ Boley (2002) Intestinal ischemia M Feldman LS Friedman MH Sleisenger (Eds) Gastrointestinal and liver disease EditionNumber7th ed Saunders Philadelphia
K Fitch SJ Bernstein MS Aguilar B Burnand JR LaCalle P Lazaro et al. (2001) The RAND/UCLA appropriateness method user's manual RAND Santa Monica, CA
SM Campbell J Braspenning A Hutchinson M Marshall (2002) ArticleTitleResearch methods used in developing and applying quality indicators in primary care Qual Saf Health Care 11 358–64 Occurrence Handle12468698 Occurrence Handle10.1136/qhc.11.4.358 Occurrence Handle1:STN:280:DC%2BD3s%2FlslSgsA%3D%3D
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kobayashi, K., Ueno, F., Bito, S. et al. Development of consensus statements for the diagnosis and management of intestinal Behçet's disease using a modified Delphi approach. J Gastroenterol 42, 737–745 (2007). https://doi.org/10.1007/s00535-007-2090-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00535-007-2090-4